Home
Dashboard
Bookmarks
Portfolios
ExplorerFunds
Equities
Library
Insights
Pinindices
MobileApp Store
Android

Health Care

Medical Robotics for SurgeryA fast evolving market, technological advance and new potential entrants
Medical Robotics for Surgery
  • -10.5%
  • 9
  • 8
Healthcare Innovation ETFsDeeply transformative healthcare expectations or ever hopeful promises of basic research advance
Healthcare Innovation ETFs
  • 36.8%
  • 9
Cannabis - focused ETFsWith a focus on US-based cannabis operators, some ETF highflyers signal the potential of the domestic market and major regulatory uncertainty
Cannabis - focused ETFs
  • -13.1%
  • 7
Biotechnology Breakthroughs ETFsDiversified selections or focused investment models in Biotech R&D
Biotechnology Breakthroughs ETFs
  • 43.8%
  • 10
Vaccines markets are collaborative and competitiveWith just 4 major pharmaceutical companies in the lead and 2 powerful mRNA newcomers
Vaccines markets are collaborative and competitive
  • 71.5%
  • 12
  • 5
China Healthcare Logistics - Shock WavesTightly integrated medical ecosystems are upending healthcare logistics in China and around the world
China Healthcare Logistics - Shock Waves
  • -37.5%
  • 10
  • 1
Cell Therapies - Gene EditingInvesting in clinical trial firms, a high stakes bet on breakthrough research
Cell Therapies - Gene Editing
  • -17.3%
  • 19
Next 60 MidCap Biotech FirmsWith market capitalizations between $2bn and $10bn, the performance of the midcap biotech selection has gained momentum
Next 60 MidCap Biotech Firms
  • 66.4%
  • 61
Cancer, Rare Diseases & Cell TherapiesResearch Breakthrough and Pricing Challenges
Cancer, Rare Diseases & Cell Therapies
  • 34.7%
  • 26
  • 2
China Biotech - Rising Stars ?Concentrating minds on breakthrough medication - Chinese biotech with a mission
China Biotech - Rising Stars ?
  • 7.6%
  • 11
  • 2
Biotechnology - Genetic Revolutions Small- and Mid-Cap biotech firms at the forefront of DNA manipulations and gene therapies
Biotechnology - Genetic Revolutions
  • 24.3%
  • 42
US NASDAQ 100 ETFsA selection of ETFs seeking to track NASDAQ indices and factors, with a range of filters and of option overlays
US NASDAQ 100 ETFs
  • 14.2%
  • 10
30 Biotech LargeCap Firms The biotech firms, with market capitalization exceeding $10 billion, are strong contributors to the industry's performance - Momentum is indicative of the sector's resilience
30 Biotech LargeCap Firms
  • 56.2%
  • 30
Technology - ARK Innovation, prophet or poster childThe technology fund has been frontrunning market trends on the way up and is riding high, once again
Technology - ARK Innovation, prophet or poster child
  • 28.1%
  • 20
Next 60 Small-Cap BiotechSelection of small market cap biotech firms, below $2 billion
Next 60 Small-Cap Biotech
  • 33.5%
  • 60
Health Care Devices & Services ETFsEvaluating dedicated health care funds in aging societies
Health Care Devices & Services ETFs
  • 17.9%
  • 4
Pharmaceuticals MajorsDistinctive strenghts to meet industry challenges
Pharmaceuticals Majors
  • 63.0%
  • 25
  • 5
Pharma GenericsNew opportunities or an uncertain future ?
Pharma Generics
  • 10.7%
  • 8
  • 1
Diagnostics Revolutions A focus on advanced medical equipment for in-vitro diagnostics in laboratories and in research
Diagnostics Revolutions
  • 44.0%
  • 23
Cannabis meanderingsMarijuana legalization will probably be staged, one step at a time
Cannabis meanderings
  • -8.2%
  • 20
  • 4
China Healthcare - Towering domestic challengesAn ecosystem of thousands of Chinese pharmaceutical manufacturers supporting domestic needs and global exports
China Healthcare - Towering domestic challenges
  • -17.3%
  • 8
  • 1
Germany - Market Cap $20bn to $50bnWith a show of resilience, selective exposure to China -a bet on a resurgent German domestic market
Germany - Market Cap $20bn to $50bn
  • 0.9%
  • 17
Chronic Diseases Confronting diabetes, and many other critical public health problems
Chronic Diseases
  • 3.2%
  • 15
  • 4
Sector rotation - Tech industries lose momentumPowerful Pininvest features for analysis of major potential market shifts between sectors and industries
Sector rotation - Tech industries lose momentum
  • 4.9%
  • 6
Swiss Companies - Mid Cap U.S. listingsWith market capitalizations of $2bn to $10bn, MidCap firms, some unfamiliar, with potential investment opportunities
Swiss Companies - Mid Cap U.S. listings
  • 9.9%
  • 34
Global Health Care ETFsDedicated funds with distinct performance / volatility profiles and investment options
Global Health Care ETFs
  • 34.6%
  • 16
Healthcare - Collaboration in CRISPR ExpertiseA focus on collaborations between giant healthcare companies and clinical trial and research firms - signaling high-value potential (and high-stake bets)
Healthcare - Collaboration in CRISPR Expertise
  • -5.6%
  • 8
Biotechnology - Top 100 by Market CapTargeted access to a large selection of biotechnology and pharmaceutical stocks (large-, mid- and small-cap)
Biotechnology - Top 100 by Market Cap
  • 58.1%
  • 100
Biotech Movers - a January '23 SurpriseReversal of the negative 2022 trend of biotech firms has been notable - the industry remains volatile but investments could be rewarding
Biotech Movers - a January '23 Surprise
  • 30.3%
  • 17
Medical Advancement, Health and Wellbeing ETFsTaking a long view on transformative trends in healthcare and wellbeing
Medical Advancement, Health and Wellbeing ETFs
  • 28.7%
  • 7
HeathcareLarge cap equities controlled for volatility
Heathcare
  • 45.0%
  • 50